The stereoselective baker's yeast reduction of various N-protected pip
eridone-carboxylic acids have been studied, and the enantioselectivity
was found to be widely dependent on whether fermenting or non-ferment
ing conditions were employed. Thus reaction of N-tert-butoxycarbonyl-4
-oxopiperidine-3-carboxylic acid ethyl eater (6) with fermenting baker
's yeast gave almost racemic rt-butoxycarbonyl-4-hydroxypiperidine-3-c
arboxylic acid ethyl ester (7), however, with complete diastereoselect
ivity. Reduction of 6 with non-fermenting yeast gave 7 with a 24-41% e
nantiomeric excess. Similarly, reduction of N-tert-butoxycarbonyl-3-ox
opiperidine-4-carboxylic acid ethyl ester (17) with fermenting baker's
yeast gave racemic rt-butoxycarbonyl-3-hydroxypiperidine-4-carboxylic
acid ethyl ester [(+/-)-18] diastereoselectively. A convenient method
for determining the enantiomeric excess of the hydroxypiperidine carb
oxylic acids derivatives was found in the reaction with Sanger's reage
nt followed by HPLC on a chiral column.